Management of Severe Atopic Dermatitis in Pediatric Patients

Jennifer B. Mancuso, Stephanie S. Lee, Amy S. Paller, Yukihiro Ohya, Lawrence F. Eichenfield*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Atopic dermatitis is a common, chronic inflammatory skin disorder, present in about 12% of children worldwide. Optimizing management of severe atopic dermatitis in pediatric patients is critical to reduce signs of inflammation, alleviate pruritus and sleep disturbance, minimize the development and/or impact of comorbidities, and improve the patient and caregiver's quality of life. Evaluating the longitudinal severity of pediatric atopic dermatitis is an important component of measuring therapeutic response and long-term management, and is different in clinical practice versus clinical trials. This article describes when and how to use different treatments for pediatric patients with severe atopic dermatitis, including topical medications, phototherapy, and systemic medical therapies (traditional immunosuppressants, biologics, and small molecule inhibitors). It also provides recommendations useful in clinical practice for nonpharmacologic interventions for pediatric patients with severe atopic dermatitis.

Original languageEnglish (US)
Pages (from-to)1462-1471
Number of pages10
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume9
Issue number4
DOIs
StatePublished - Apr 2021

Keywords

  • Atopic dermatitis
  • Biologics
  • Immunosuppressive agents
  • Phototherapy
  • Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Management of Severe Atopic Dermatitis in Pediatric Patients'. Together they form a unique fingerprint.

Cite this